Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)Volkmar Boehme, Norbert Schmitz, Ulrich Kaiser et al.|Annals of Oncology|2006Cited by 280
Safety of Front-Line R-Mini-CHOP with or without Acalabrutinib in Older Adults with DLBCL - an Interim Analysis of Serious Adverse Events in the Arched / GLA 2022-1 Randomized, Open-Label, Phase 3 TrialKonstantinos Christofyllakis, Mathias Rummel, Igor Age Kos et al.|Blood|2024Cited by 0